These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 16491070)

  • 21. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
    Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
    Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation as a regulatory mechanism for gene expression in mammals.
    Serman A; Vlahović M; Serman L; Bulić-Jakus F
    Coll Antropol; 2006 Sep; 30(3):665-71. PubMed ID: 17058541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.
    Frigola J; Song J; Stirzaker C; Hinshelwood RA; Peinado MA; Clark SJ
    Nat Genet; 2006 May; 38(5):540-9. PubMed ID: 16642018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic alterations and cancer: new targets for therapy.
    Allen A
    IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation: the nuts and bolts of repression.
    Miranda TB; Jones PA
    J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG-island methylation and epigenetic control of resistance to chemotherapy.
    Teodoridis JM; Strathdee G; Plumb JA; Brown R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epigenetic alterations in cancer].
    Toyota M; Suzuki H; Imai K; Shinomura Y
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2043-8. PubMed ID: 17471906
    [No Abstract]   [Full Text] [Related]  

  • 34. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.
    Sato H; Suzuki H; Toyota M; Nojima M; Maruyama R; Sasaki S; Takagi H; Sogabe Y; Sasaki Y; Idogawa M; Sonoda T; Mori M; Imai K; Tokino T; Shinomura Y
    Carcinogenesis; 2007 Dec; 28(12):2459-66. PubMed ID: 17675336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant promoter hypermethylation in biliary tract carcinoma.
    Kohya N; Koga Y; Kitajima Y; Miyazaki K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
    Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
    Lee J; Yoon YS; Chung JH
    Gynecol Oncol; 2008 May; 109(2):270-4. PubMed ID: 18377964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.